Dismukes R K, Mulder A H
Eur J Pharmacol. 1976 Oct;39(2):383-8. doi: 10.1016/0014-2999(76)90148-5.
Oxymetazoline (an alpha-receptor agonist) reduced and phentolamine (an alpha-receptor antagonist) increased depolarization-induced release (potassium or electrical field stimulation) of 3H-noradrenaline (NA) from superfused neocortical slices in a dose-dependent way. Inhibition of phosphodiesterase also reduced NA release; this effect could be reversed by phentolamine. Phosphodiesterase inhibition potentiated the effect of oxymetazoline. It is suggested that stimulation of presynaptic alpha-receptors may reduce NA release up to about 60% and that increased cyclic AMP formation might be involved in this modulation.
羟甲唑啉(一种α受体激动剂)可降低,而酚妥拉明(一种α受体拮抗剂)可增加去极化诱导的3H-去甲肾上腺素(NA)从灌流的新皮质切片中的释放(钾或电场刺激),且呈剂量依赖性。磷酸二酯酶的抑制也可减少NA的释放;这种作用可被酚妥拉明逆转。磷酸二酯酶抑制增强了羟甲唑啉的作用。提示突触前α受体的刺激可能使NA释放减少达约60%,且环磷酸腺苷形成增加可能参与了这种调节。